ID: ALA5307579

Max Phase: Preclinical

Molecular Formula: C23H31NO3

Molecular Weight: 369.51

Associated Items:

Representations

Canonical SMILES:  C#CC1(OC(C)=O)CCC2C3CCC4=CC(=NO)CCC4C3CCC21CC

Standard InChI:  InChI=1S/C23H31NO3/c1-4-22-12-10-19-18-9-7-17(24-26)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)27-15(3)25/h2,14,18-21,26H,4,6-13H2,1,3H3

Standard InChI Key:  KIQQMECNKUGGKA-UHFFFAOYSA-N

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 369.51Molecular Weight (Monoisotopic): 369.2304AlogP: 4.71#Rotatable Bonds: 2
Polar Surface Area: 58.89Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.47CX Basic pKa: 3.11CX LogP: 4.11CX LogD: 4.11
Aromatic Rings: 0Heavy Atoms: 27QED Weighted: 0.33Np Likeness Score: 1.62

References

1. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL..  (2019)  Mapping human microbiome drug metabolism by gut bacteria and their genes.,  570  (7762): [PMID:31158845] [10.1038/s41586-019-1291-3]